Approximately, 20–60% of patients with t-MNs possess somatic variants in various genes strongly associated with CH, including DNMT3A, TET2, ASXL1, PPM1D, and TP53 (Travaglini et al., 2024). Here, TET2 is linked to cyclic hematopoiesis.